compounded semaglutide fda news Semaglutide: Legal & Safe 2026 FDA Ban on Compounded GLP-1

10 Ongoing trials are currently studying semaglutide and tirzepatide for alcohol use disorder, semaglutide for opioid use and cannabis use disorder, liraglutide for opioid use disorder, and semaglutide and exenatide to achieve smoking cessation

Common early complaints can include: Nausea or a mildly unsettled stomach Feeling full after smaller meals Reduced interest in food Bloating or belching Indigestion or heartburn Diarrhea Constipation Abdominal discomfort Fatigue These symptoms overlap with adverse reactions listed in current prescribing information for Wegovy and Zepbound

Semaglutide side effects are well-documented and often manageable with slow titration and dietary adjustments

EmSculpt Neo addresses muscle tone by simultaneously addressing fat and building muscle, using radiofrequency energy and high-intensity focused electromagnetic energy, helping patients achieve a more toned, contoured result in areas like the abdomen, arms and legs